Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hepatitis C: global epidemiology and strategies for control

Published byNelson Kelly Modified over 6 years ago

Similar presentations

Presentation on theme: "Hepatitis C: global epidemiology and strategies for control"— Presentation transcript:

1 Hepatitis C: global epidemiology and strategies for control
S. Lanini, P.J. Easterbrook, A. Zumla, G. Ippolito  Clinical Microbiology and Infection  Volume 22, Issue 10, Pages (October 2016) DOI: /j.cmi Copyright © 2016 World Health Organization Terms and Conditions

2 Fig. 1 Framework for the global health sector strategy on viral hepatitis, 2016–2021 [76]. Clinical Microbiology and Infection  , DOI: ( /j.cmi ) Copyright © 2016 World Health Organization Terms and Conditions

Download ppt "Hepatitis C: global epidemiology and strategies for control"

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial  P.J. van der Geest, M. Mohseni, D. Nieboer,

Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial  P.J. van der Geest, M. Mohseni, D. Nieboer,
Cryptococcosis—the impact of delay to diagnosis

Cryptococcosis—the impact of delay to diagnosis
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Next-generation sequencing technologies and their application to the study and control of bacterial infections  J. Besser, H.A. Carleton, P. Gerner-Smidt,

Next-generation sequencing technologies and their application to the study and control of bacterial infections  J. Besser, H.A. Carleton, P. Gerner-Smidt,
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
I.J. Schalk  Clinical Microbiology and Infection 

I.J. Schalk  Clinical Microbiology and Infection 
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 

O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 

D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J

E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?

Migrant health—a cause for concern?
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 

J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis

Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection

Virological tools to diagnose and monitor hepatitis C virus infection
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Refugee crisis and re-emergence of forgotten infections in Europe

Refugee crisis and re-emergence of forgotten infections in Europe

Similar presentations

Ads by Google